Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
Virios Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 25, 2024
Virios Therapeutics reported fiscal year 2023 executive compensation information on April 25, 2024.
In 2023, three executives at Virios Therapeutics received on average a compensation package of $405K, a 37% decrease compared to previous year.
Average pay of disclosed executives at Virios Therapeutics
Greg Duncan, Chief Executive Officer, received $567K in total, which decreased by 39% compared to 2022. 93% of Duncan's compensation, or $529K, was in salary. Duncan also received $38K in other compensation.
R. Michael Gendreau, Chief Medical Officer, received a compensation package of $365K, which decreased by 36% compared to previous year. 92% of the compensation package, or $336K, was in salary.
Angela Walsh, Senior Vice President of Finance, earned $283K in 2023, a 34% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2024.